These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 25335122

  • 1. 300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis.
    Serrano E, Wahn HU, Didier A, Bachert C.
    Am J Rhinol Allergy; 2014; 28(6):471-6. PubMed ID: 25335122
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.
    Cox LS, Casale TB, Nayak AS, Bernstein DI, Creticos PS, Ambroisine L, Melac M, Zeldin RK.
    J Allergy Clin Immunol; 2012 Dec; 130(6):1327-34.e1. PubMed ID: 23122534
    [Abstract] [Full Text] [Related]

  • 3. Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents.
    Halken S, Agertoft L, Seidenberg J, Bauer CP, Payot F, Martin-Muñoz MF, Bartkowiak-Emeryk M, Vereda A, Jean-Alphonse S, Melac M, Le Gall M, Wahn U.
    Pediatr Allergy Immunol; 2010 Sep; 21(6):970-6. PubMed ID: 20718927
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial.
    Maloney J, Bernstein DI, Nelson H, Creticos P, Hébert J, Noonan M, Skoner D, Zhou Y, Kaur A, Nolte H.
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):146-153.e2. PubMed ID: 24468255
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
    Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le Gall M, Melac M, Malling HJ.
    J Allergy Clin Immunol; 2011 Sep; 128(3):559-66. PubMed ID: 21802126
    [Abstract] [Full Text] [Related]

  • 9. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
    Senna GE, Calderon M, Milani M.
    Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W.
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
    Ellis AK, Tenn MW, Steacy LM, Adams DE, Day AG, Walker TJ, Nolte H.
    Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Monoid sublingual immunotherapy.
    Palma-Carlos AG, Santos AS, Branco-Ferreira M, Pregal AL, Palma-Carlos ML.
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
    [Abstract] [Full Text] [Related]

  • 19. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
    Wolthers OD, Høst A, Frederiksen B, Halken S.
    Ugeskr Laeger; 2012 Aug 27; 174(35):1989-92. PubMed ID: 22929576
    [Abstract] [Full Text] [Related]

  • 20. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.
    Dahl R, Stender A, Rak S.
    Allergy; 2006 Feb 27; 61(2):185-90. PubMed ID: 16409194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.